#Dose

Russia, if you’re listening...

mathvink

Very encouraging.Only downside of this vaccine (and Pfizer’s, which is also messenger RNA-based) is that it apparently still needs two doses to achieve this level of protection.https://twitter.com/cnnbrk/status/1328308048402784262 Side ef

brendan

brendan_49

$ANNX was founded on Ben Barres discovery that C1q prunes synapses in normal development and neurodegen. ANNX ultimate aim, I think, is Alzheimers, but more efficient paths first in Guillain-Barre

Dear Pandemic

DearPandemic

1/ Q: What’s going on with the new #johnsonandjohnson/#janssen vaccine results?A: Some very positive signs for immune responses from newly published Phase 1/2 trial results, & Phase 3 efficacy results

Jim Al-Khalili

jimalkhalili

1/6 We need clear, transparent information on issue of delaying the 2nd Pfizer jab from 3 weeks to 12 weeks. Pfizer don't know if this is a good idea because

Fionna O'Leary, 🕯🇪🇺

fascinatorfun

Thanks for this incredibly helpful analysis @dgurdasani1 Two questions. 1/ Does this summarise the AZ published data :The plan is to extend the time interval for all age groups despite

Dr. Tim 'Stick' Szczykutowicz

Prof_TimStick

1/11 #UnsolicitedArticleReview Authors link radiology leadership prioritizing CT protocol teams with dose reduction amounts. Awesome paper! https://doi.org/10.1016/j.jacr.2020.01.044@JACRJournal @aapmHQ @ctisus @CtSpectral @SABImaging @EFOM

Alex Berenson

AlexBerenson

1/ Through Dec. 22, with fewer than 1 million doses of the #Covid vaccine given, @cdcgov's vaccine injury reporting system received 307 reports of ER visits and 17 "life threatening"

Mark Horowitz

markhoro

How to taper antipsychotic medication to minimise withdrawal problems: more slowly than you think, down to fractions of usually used doses. Might need liquid versions, pill cutters. Thks Robin Murray,

Rupert Pearse

rupert_pearse

Optimistic news: National data on new coronavirus infections data do now show we have passed the peak. Good news but really this is just the end of the beginning for

Richard Torriani

richardtorriani

Today the FDA released Pfizer’s Phase III vaccine trial data. This is big, as this is the first time we, scientists, have seen the data. Pfizer’s report was 92 pages

Hugo Gye

HugoGye

NEWBoris Johnson says 1.3m people have been vaccinated across UK, 1.1m in England.650,000 of them are over-80 which is 23% of that cohort. DAILY UPDATES ON VACCINATION FIGURES ARE COMING

Drew Armstrong

ArmstrongDrew

There were two VERY big pieces of vaccine news out in the last 24 hours:1)J&J's vaccine (one shot, easier to store) had 66% efficacy at preventing moderate/severe infections. 2) Novavax

Mac n’ Chise 🧬🧫🦠

sailorrooscout

More promising mRNA vaccine data! This time from Moderna. A new Phase II study shows that half-doses (50 μg) of our vaccine appear to be as effective as full doses

Fionna O'Leary, 🕯🇪🇺

fascinatorfun

VACCINE SURVEILLANCE AND STRATEGY THIS LOOKS HOPEFUL, subject to provisos.https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/951189/COVID-19_vaccine_surveillance_strategy.pdf PROVISOS- everyone i

Hilda Bastian, PhD

hildabast

New data for the Oxford/AstraZeneca vaccine, with extra month's worth of data, & combining 4 trials from phase 1 to 3, focusing on 1st dose: Indian phase 2/3 trial still

alan drummond

alandrummond2

A shot of euphoria, a dose of regret: Some health-care professionals who got vaccinated before front-line workers have second thoughts - Toronto Star, January 16. The vaccine, initially a symbol

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.